AI assistant
Lipocine Inc. — Director's Dealing 2018
Dec 6, 2018
35074_dirs_2018-12-06_d9698aad-d013-4bb1-8680-a77af25af0d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2018-12-04
Reporting Person: Patel Mahesh V. (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-04 | Restricted stock unit | $0 | A | 290000 | Acquired | 2028-12-04 | Common Stock (290000) | Direct |
| 2018-12-04 | Stock Option (Right to Buy) | $1.46 | A | 150000 | Acquired | 2028-12-04 | Common Stock (150000) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit
F2: Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020.
F3: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 4, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.